Cross-sectional evaluation of surface contamination with 9 antineoplastic drugs in 93 Canadian healthcare centers: 2019 results

J Oncol Pharm Pract. 2020 Mar 1;1078155220907125. doi: 10.1177/1078155220907125. Online ahead of print.
No abstract available